LUBIPROSTONE
Clinical Indication
Constipation
Comments
Withdrawn from market
Date of classification
September 2021
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.